hat
Turinabol se yon derive nan dianabol ki te sibi modifikasyon sèten nan estrikti chimik li yo. Diferans ki pi gwo ant de estewoyid yo se prezans nan chanjman 4-chloro nan turinabol, ki bay li pwopriyete invizibl ak dianabol. An reyalite, sa a ka chanje tou pou Clostebol. Mèsi a estrikti sa a adisyonèl, turinabol pa ka kominike avèk anzim nan aromatase, fè li enposib pou sa a esteroyid konvèti nan estwojèn. Se konsa, itilizatè a pa bezwen enkyete sou sa yo efè segondè estwojèn kòm retansyon dlo, ogmante san presyon, gynecomastia, ak larim akimilasyon grès. Pou rezon sa a, pa gen okenn inhibiteur aromatase (AI) ki nesesè lè tbol yo itilize pou kont li, oswa ansanm ak lòt estewoyid ki pa aromatisé.
eng
Turinabol is a derivative of dianabol that has undergone certain modifications in its chemical structure. The major difference between the two steroids is the presence of 4-chloro alteration in turinabol, which gives it properties unseen with dianabol. In fact, this alteration can also be observed with Clostebol. Thanks to this additional structure, turinabol can not interact with the aromatase enzyme, making it impossible for this steroid to convert into estrogen. Thus, the user does not need to worry about such estrogenic side effects as water retention, increased blood pressure, gynecomastia, and subcutaneous fat accumulation. For this reason, no aromatase inhibitors (AI) are needed when tbol is used alone, or together with other non-aromatizing steroids.